494 related articles for article (PubMed ID: 24095883)
21. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
22. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Pitisuttithum P; Velicer C; Luxembourg A
Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of the prophylactic HPV vaccine: an application to the Netherlands taking non-cervical cancers and cross-protection into account.
Luttjeboer J; Westra TA; Wilschut JC; Nijman HW; Daemen T; Postma MJ
Vaccine; 2013 Aug; 31(37):3922-7. PubMed ID: 23806241
[TBL] [Abstract][Full Text] [Related]
24. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.
Bosch FX; Tsu V; Vorsters A; Van Damme P; Kane MA
Vaccine; 2012 Nov; 30 Suppl 5():F1-11. PubMed ID: 23199951
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
[TBL] [Abstract][Full Text] [Related]
26. Indications for the HPV vaccine in adolescents: a review of the literature.
Soares GR; Vieira Rda R; Pellizzer EP; Miyahara GI
J Infect Public Health; 2015; 8(2):105-16. PubMed ID: 25453595
[TBL] [Abstract][Full Text] [Related]
27. Spatial patterns of human papillomavirus-associated cancers within the state of Minnesota, 1998-2007.
Nelson EJ; Hughes J; Kulasingam SL
Spat Spatiotemporal Epidemiol; 2014 Jun; 9():13-21. PubMed ID: 24889990
[TBL] [Abstract][Full Text] [Related]
28. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
[TBL] [Abstract][Full Text] [Related]
29. Post-licensure monitoring of HPV vaccine in the United States.
Markowitz LE; Hariri S; Unger ER; Saraiya M; Datta SD; Dunne EF
Vaccine; 2010 Jul; 28(30):4731-7. PubMed ID: 20188681
[TBL] [Abstract][Full Text] [Related]
30. Getting to know human papillomavirus (HPV) and the HPV vaccines.
Smith GD; Travis L
J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
[TBL] [Abstract][Full Text] [Related]
31. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
Ryerson AB; Peters ES; Coughlin SS; Chen VW; Gillison ML; Reichman ME; Wu X; Chaturvedi AK; Kawaoka K
Cancer; 2008 Nov; 113(10 Suppl):2901-9. PubMed ID: 18980273
[TBL] [Abstract][Full Text] [Related]
32. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
Forte T; Niu J; Lockwood GA; Bryant HE
Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
[TBL] [Abstract][Full Text] [Related]
33. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study.
Brisson M; Laprise JF; Drolet M; Van de Velde N; Franco EL; Kliewer EV; Ogilvie G; Deeks SL; Boily MC
Vaccine; 2013 Aug; 31(37):3863-71. PubMed ID: 23830974
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus vaccine update.
Gilmer LS
Prim Care; 2015 Mar; 42(1):17-32. PubMed ID: 25634702
[TBL] [Abstract][Full Text] [Related]
35. The HPV infection in males: an update.
Giraldi G; De Luca d'Alessandro E
Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
[TBL] [Abstract][Full Text] [Related]
36. HPV-linked oral cancer: another argument for universal HPV vaccination of boys and girls.
Laurence J
AIDS Read; 2008 Jul; 18(7):345-6. PubMed ID: 18655309
[No Abstract] [Full Text] [Related]
37. Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages.
Videla S; Darwich L; Cañadas M; Clotet B; Sirera G
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):947-57. PubMed ID: 24865412
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus, cervical cancer, and the vaccines.
Tovar JM; Bazaldua OV; Vargas L; Reile E
Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
[TBL] [Abstract][Full Text] [Related]
39. Ten Years of Human Papillomavirus Vaccination in the United States.
Markowitz LE; Gee J; Chesson H; Stokley S
Acad Pediatr; 2018 Mar; 18(2S):S3-S10. PubMed ID: 29502635
[TBL] [Abstract][Full Text] [Related]
40. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
Dunne EF; Datta SD; E Markowitz L
Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
